STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

75 hedge funds and large institutions have $119M invested in Stemline Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+1
Holders Change %
+1.35%
% of All Funds
1.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
33
Reduced
15
Closed
14
Calls
$2.41M
Puts
$1.18M
Net Calls
+$1.23M
Net Calls Change
+$881K
Name Holding Trade Value Shares
Change
Shares
Change %
CS
76
Candriam SCA
Luxembourg
-$2.61M -244,000 Closed
Invesco
77
Invesco
Georgia
-$1.81M -169,058 Closed
BIM
78
Bogle Investment Management
Massachusetts
-$1.02M -94,945 Closed
Renaissance Technologies
79
Renaissance Technologies
New York
-$701K -65,500 Closed
CLOS
80
Compagnie Lombard Odier SCmA
Switzerland
-$647K -60,500 Closed
Acadian Asset Management
81
Acadian Asset Management
Massachusetts
-$640K -59,756 Closed
OAM
82
Oxford Asset Management
United Kingdom
-$431K -40,298 Closed
JPMorgan Chase & Co
83
JPMorgan Chase & Co
New York
-$269K -25,121 Closed
CS
84
Credit Suisse
Switzerland
-$123K -11,483 Closed
PA
85
Perceptive Advisors
New York
-$115K -10,702 Closed
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
-$90K -6,836 Closed
AIM
87
Acrospire Investment Management
Illinois
-$7K -635 Closed
Federated Hermes
88
Federated Hermes
Pennsylvania
-$4K -400 Closed